P3.01-01 Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC PatientsYiqiang Wu, Zhiyong Liang, G.X. Wu et al.|Journal of Thoracic Oncology|2018Cited by 0